Tg Therapeutics Inc (TGTX)

EBITDA Growth

-42.25%

Quarterly · Period ending:

TGTX logo

TGTX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-42.25%
TGTX Quarterly EBITDA YoY % (-900.00% → -42.25%)
High-resolution chart · PNG

TGTX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
85.9236%
490.292%
-88.9302%
-340.1176%
-40.2675%
25%
58.3333%
-187.5%
23.0769%
50%
-20%
147.0588%
-62.5%
-33.3333%
9.0909%
-183.3333%
-900%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.